Dr. Reddy's Laboratories Ltd (RDY)

Healthcare

$12.48

+2.30%

nightly snapshot · 10/11/2026

ALPHASCORE™ · C+ · Neutral

ALPHASCORE

54

/ 100

C+

NEUTRAL

▲ 0 · 30D

KEY FUNDAMENTALS

P/E28.4

ROE8.8%

NET MARGIN12.8%

GROSS MARGIN52.8%

MKT CAP$10.40B

loading full analysis…

DAILY BRIEF

Dr. Reddy's Laboratories Ltd achieves an AlphaScore of 54/100 from the 2026-10-11 snapshot. Relevant metrics show a gross margin of 52.77% and a net margin of 12.76%. A notable strength is its low debt-to-equity ratio of 0.19, indicating strong financial safety. Conversely, a risk is its modest revenue growth of 3.19%.

Written 11/10/2026, 00:38:18 UTC · Snapshot 11/10/2026